| Biomarker ID | 1859 |
| PMID | 30374275 |
| Year | 2018 |
| Biomarker | PDGF-BB/Cr (Platelet Derived Growth Factor-BB/creatinine) |
| Biomarker Basis | Concentration Based (ng/mg) |
| Biomolecule | Protein |
| Source | Urine |
| Subjects | Humans |
| Regulation | Upregulated in Recurrent PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | OR: 1.04 (95% CI: 1.01-1.08) |
| Effect on Pathways | Pathway include: RET signaling; Apoptotic Pathways in Synovial Fibroblasts; GPCR Pathway; PI3K/AKT activation; ERK Signaling |
| Experiment | Prostate Cancer Vs No Prostate Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | 118 patients were chosen for analysis in this study |
| Senstivity | 67.5% |
| Specificity | 52.6% |
| AUC | 0.6362 |
| Accuracy | NA |
| Level Of Significance | p=0.016 |
| Method Used | ELISA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |